The global Embolization Particle market size was valued at USD 1915.55 Million in 2022 and will reach USD 3468.24 Million in 2028, with a CAGR of 10.4% during 2022-2028.
Embolization is a minimally invasive therapy to stop bleeding as well as to stop blood flow to a tumor in order to shrink it or in preparation for removal. In this procedure, some embolized particles or substances are injected into the veins of the patients to block or reduce the blood flow to cancer cells. Embolization is an option for some patients with tumors that cannot be removed by surgery. It can be used for tumors that are too large to be treated with ablation (usually larger than 5 cm thickness). It can also be used with ablation. Embolization does reduce some of the blood supply to the normal liver tissue, so it may not be a good option for some patients whose liver has been damaged by diseases such as hepatitis or cirrhosis. Embolization is used in many procedures as a part of interventional radiology.
Drivers
The Americas dominates the global embolic particle market. Good factors, high market maturity, technical and financial advantages, production capacity, and the development of new technologies, the availability of advanced hospital infrastructure and the availability of skilled healthcare professionals have further increased market growth.
Europe is paying more and more attention to the rapid diagnosis and treatment of cancer, changing lifestyles, increasing the prevalence of cancer in the elderly population, and occupying a second place in the market on the basis of an aging population.
The Asia Pacific region is the fastest growing market as there are more developing countries in the region, such as India and China. These countries are encouraging the development of health care. In addition, increasing the number of cancers in patients in developing countries will directly increase the demand for various diagnostic and therapeutic approaches, which in turn will drive market growth.
The Middle East and Africa are expected to have the smallest market share due to the low availability of medical facilities and the low growth in the medical sector. However, countries such as Qatar and Kuwait are paying more attention to the medical sector and developing medical facilities, which will drive the market in the region.
Region Overview:
North America had the highest growth rate of all regions.
Company Overview:
Boston Scientific Corporation is one of the major players operating in the Embolization Particle market, holding a share of 22.27% in 2018.
Boston Scientific Corporation has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies. The structured agreement includes drug-eluting microspheres designed to be loaded with chemotherapy drugs for delivery to cancerous tumors, and spherical embolic products used to treat uterine fibroids and other conditions. The transaction consists of an upfront payment of $70 million and additional payments contingent on regulatory and sales milestones.
Terumo Corporation announced recently that it has entered into an agreement (hereafter "the acquisition") to purchase Sequent Medical, Inc. (California, United States; hereafter "Sequent"), a privately-held firm developing a new medical device for aneurysm embolization. The purchase price of $280M will be paid at closing, with up to $100M more to be paid based on the achievement of specific development or commercial milestones. The acquisition is a key element in Terumo’s new growth strategy to establish and expand its global presence in the neurovascular market and other rapidly growing markets. Terumo has also identified the cardiology and endovascular markets as potential areas for growth.
Segmentation Overview:
Among different product types, PVA segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Oncology segment occupied the biggest share from 2017 to 2022.
The Embolization Particle market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Embolization Particle market covered in Chapter 4:
Medtronic
Cook Medical
Hengrui
Terumo
BTG Medical
Boston Scientific Corporation
Sirtex Medical Limited
Merit Medical
In Chapter 12 and Chapter 14.1, on the basis of types, the Embolization Particle market from 2018 to 2028 is primarily split into:
PVA
Microspheres
Gelfoam
Others
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Embolization Particle market from 2018 to 2028 covers:
Oncology
Prostate Disease
Peripheral Vascular Disease
Neurology
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Embolization Particle market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Embolization Particle market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Embolization Particle industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Embolization Particle industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Embolization Particle market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Embolization Particle market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Embolization Particle market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Embolization Particle market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Embolization is a minimally invasive therapy to stop bleeding as well as to stop blood flow to a tumor in order to shrink it or in preparation for removal. In this procedure, some embolized particles or substances are injected into the veins of the patients to block or reduce the blood flow to cancer cells. Embolization is an option for some patients with tumors that cannot be removed by surgery. It can be used for tumors that are too large to be treated with ablation (usually larger than 5 cm thickness). It can also be used with ablation. Embolization does reduce some of the blood supply to the normal liver tissue, so it may not be a good option for some patients whose liver has been damaged by diseases such as hepatitis or cirrhosis. Embolization is used in many procedures as a part of interventional radiology.
Drivers
The Americas dominates the global embolic particle market. Good factors, high market maturity, technical and financial advantages, production capacity, and the development of new technologies, the availability of advanced hospital infrastructure and the availability of skilled healthcare professionals have further increased market growth.
Europe is paying more and more attention to the rapid diagnosis and treatment of cancer, changing lifestyles, increasing the prevalence of cancer in the elderly population, and occupying a second place in the market on the basis of an aging population.
The Asia Pacific region is the fastest growing market as there are more developing countries in the region, such as India and China. These countries are encouraging the development of health care. In addition, increasing the number of cancers in patients in developing countries will directly increase the demand for various diagnostic and therapeutic approaches, which in turn will drive market growth.
The Middle East and Africa are expected to have the smallest market share due to the low availability of medical facilities and the low growth in the medical sector. However, countries such as Qatar and Kuwait are paying more attention to the medical sector and developing medical facilities, which will drive the market in the region.
Region Overview:
North America had the highest growth rate of all regions.
Company Overview:
Boston Scientific Corporation is one of the major players operating in the Embolization Particle market, holding a share of 22.27% in 2018.
Boston Scientific Corporation has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies. The structured agreement includes drug-eluting microspheres designed to be loaded with chemotherapy drugs for delivery to cancerous tumors, and spherical embolic products used to treat uterine fibroids and other conditions. The transaction consists of an upfront payment of $70 million and additional payments contingent on regulatory and sales milestones.
Terumo Corporation announced recently that it has entered into an agreement (hereafter "the acquisition") to purchase Sequent Medical, Inc. (California, United States; hereafter "Sequent"), a privately-held firm developing a new medical device for aneurysm embolization. The purchase price of $280M will be paid at closing, with up to $100M more to be paid based on the achievement of specific development or commercial milestones. The acquisition is a key element in Terumo’s new growth strategy to establish and expand its global presence in the neurovascular market and other rapidly growing markets. Terumo has also identified the cardiology and endovascular markets as potential areas for growth.
Segmentation Overview:
Among different product types, PVA segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Oncology segment occupied the biggest share from 2017 to 2022.
The Embolization Particle market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Embolization Particle market covered in Chapter 4:
Medtronic
Cook Medical
Hengrui
Terumo
BTG Medical
Boston Scientific Corporation
Sirtex Medical Limited
Merit Medical
In Chapter 12 and Chapter 14.1, on the basis of types, the Embolization Particle market from 2018 to 2028 is primarily split into:
PVA
Microspheres
Gelfoam
Others
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Embolization Particle market from 2018 to 2028 covers:
Oncology
Prostate Disease
Peripheral Vascular Disease
Neurology
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Embolization Particle market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Embolization Particle market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Embolization Particle industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Embolization Particle industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Embolization Particle market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Embolization Particle market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Embolization Particle market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Embolization Particle market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...